Barcelona snapshots

Prof. Paolo Fusar-Poli

Paolo Fusar-Poli psychiatrist Controversies Psiquiatry Barcelona
King's College London, UK & Università degli Studi di Pavia, Italy
Talk Tertiary pharmacological prevention for psychosis
Date Friday, September 17th, 2021
Time 16:15 - 17:00
Round Table 4. Psychotic disorders


Paolo Fusar Poli is Consultant Psychiatrist in Adult Psychiatry at the Outreach and Support in South-London (OASIS) South London and The Maudsley NHS Trust, one of the oldest and largest clinical services for the detection and prevention of mental disorders in Europe and worldwide. OASIS offers assessment and care for young people aged 14 to 35, who are seeking help for mental health issues.

Professor of Preventive Psychiatry at the Department of Psychosis Studies, Institute of Psychiatry Psychology & Neuroscience, King's College London and Associate Professor at the Department of Brain and Behavioral Sciences, University of Pavia. Author of >380 publications in PubMed journals, with an h-index of 92. Highly cited researcher (top 1% by citations for their field and year of publication) from 2015 to date. Invited speaker and/or chairman in several national and international scientific conferences. Group Head, "EPIC", Early Psychosis: Intervention and Clinical-prediction. Member of the Editorial Board and reviewer of several scientific journals. Principal investigator or co-investigator of national and international grants focused on the prevention of mental disorders. He is chair of three national and international clinical research networks.


The lecture will review current strategies to implement tertiary pharmacologic prevention of psychosis. State-of-the-art evidence will be appraised, focusing on early intervention and tertiary prevention strategies at the time of an incomplete recovery (stage 3 in the clinical staging model of psychotic disorders), in particular with respect to addressing treatment resistance, improving well-being and social skills with reduction of burden on the family, treatment of comorbid substance use, and prevention of multiple relapses and disease progression. The lecture will demonstrate that, to improve outcomes of a complex, heterogeneous syndrome such as psychosis, it is necessary to globally adopt complex models integrating a clinical staging framework and coordinated specialty care programmes that offer pre-emptive interventions to high-risk groups identified across the different stages of the disorder, including the incomplete recovery stage. Only a systematic implementation of these models of care in the national health care systems will render these strategies accessible to the 23 million people worldwide suffering from the most severe psychiatric disorders.